Drugs Made In America Acquisition Corp.
DMAA
$10.27
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 06/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 800.00 | 900.00 | 1.40K | 18.10K | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 48.90K | 70.10K | 3.60K | 60.00K | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | |
| Total Current Assets | 49.70K | 71.00K | 5.00K | 78.10K | |
|
|
|||||
| Total Current Assets | 49.70K | 71.00K | 5.00K | 78.10K | |
| Net Property, Plant & Equipment | -- | -- | -- | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 235.16M | 232.74M | 545.80K | 113.00K | |
| Total Assets | 235.21M | 232.81M | 550.80K | 191.10K | |
|
|
|||||
| Total Accounts Payable | 147.50K | -- | -- | -- | |
| Total Accrued Expenses | -- | 132.50K | 77.30K | -- | |
| Short-term Debt | -- | 60.90K | 662.30K | 210.10K | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Liabilities | 154.00K | 154.00K | 56.10K | 900.00 | |
| Total Other Current Liabilities | 154.00K | 154.00K | 56.10K | 900.00 | |
| Total Current Liabilities | 301.40K | 347.40K | 795.70K | 211.00K | |
|
|
|||||
| Total Current Liabilities | 301.40K | 347.40K | 795.70K | 211.00K | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | 60.90K | 662.30K | 210.10K | |
| Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 242.06M | 239.64M | -- | -- | |
| Total Liabilities | 242.36M | 239.98M | 795.70K | 211.00K | |
|
|
|||||
| Common Stock & APIC | 1.10K | 1.10K | 35.00K | 35.00K | |
| Retained Earnings | -6.46M | -6.33M | -279.80K | -54.90K | |
| Treasury Stock & Other | -695.80K | -852.40K | -- | -- | |
| Total Common Equity | -7.15M | -7.18M | -244.80K | -19.90K | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -7.15M | -7.18M | -244.80K | -19.90K | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -7.15M | -7.18M | -244.80K | -19.90K | |
|
|
|||||